Gail Cawkwell - 27 Jun 2022 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role: Chief Medical Officer
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol: ACRS
Transactions as of: 27 Jun 2022
Transactions value $: $0
Form type: 3
Date filed: 05 Jul 2022, 16:54
Previous filing: 15 Feb 2022
Next filing: 05 Jul 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney